{
    "abstract": "Background: The quadrivalent (q) human papillomavirus (HPV) vaccine protects against infection and disease related to HPV types 6, 11, 16, and 18. We report efficacy, immunogenicity, and safety of qHPV vaccine in a Phase 3 study in Japanese men. Methods: In this randomized, double-blind trial (NCT01862874), Japanese men (aged 16\u201326 years) were randomized in a 1:1 ratio to receive three doses of qHPV vaccine or placebo (Day 1, Month 2, Month 6). The primary efficacy endpoint was the combined incidence of HPV6/11/16/18-related persistent anogenital infection (detected at \u22652 consecutive visits \u22656 months apart), assessed in the per-protocol population of men who received all three vaccinations, and were seronegative at Day 1 and PCR negative from Day 1 to Month 7 to the relevant HPV type. Results are from the interim and final analyses. Results: In total, 1124 participants were randomized. The vaccine demonstrated 83.3% (95% confidence interval: 24.9, 98.2; p = 0.007) and 85.9% (95% confidence interval: 52.7, 97.3; p < 0.001) efficacy against HPV6/11/16/18-related persistent infection in the interim and final analyses, respectively. Two cases of HPV6/11/16/18-related external genital lesions (condyloma and PIN 1) were observed in the placebo group and none in the qHPV vaccine group at study end. At Month 7, >97% of participants who received qHPV vaccine seroconverted to each of the vaccine HPV types. Most participants remained seropositive at Month 36, although the seropositivity rate declined between Months 7 and 36. Vaccination-related adverse events were reported in 60.8% and 56.5% of participants in the qHPV vaccine and placebo groups, respectively; most commonly mild to moderate injection-site pain, erythema, and swelling. Injection-site pain and swelling were more common with qHPV vaccine than placebo (each p < 0.05). Conclusions: Results suggest qHPV vaccine is efficacious against HPV6/11/16/18-related persistent infections, immunogenic, and well-tolerated in Japanese men. Clinical trial registration identifier: NCT01862874.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Laia",
                    "initial": "L.",
                    "last": "Alemany"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Cubilla"
                },
                {
                    "first": "Gordana",
                    "initial": "G.",
                    "last": "Halec"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Kasamatsu"
                },
                {
                    "first": "Beatriz",
                    "initial": "B.",
                    "last": "Quir\u00f3s"
                },
                {
                    "first": "Emili",
                    "initial": "E.",
                    "last": "Masferrer"
                },
                {
                    "first": "Sara",
                    "initial": "S.",
                    "last": "Tous"
                },
                {
                    "first": "Bel\u00e9n",
                    "initial": "B.",
                    "last": "Lloveras"
                },
                {
                    "first": "Gustavo",
                    "initial": "G.",
                    "last": "Hern\u00e1ndez-Suarez"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Lonsdale"
                },
                {
                    "first": "Leopoldo",
                    "initial": "L.",
                    "last": "Tinoco"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Alejo"
                },
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Alvarado-Cabrero"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Laco"
                },
                {
                    "first": "Nuria",
                    "initial": "N.",
                    "last": "Guimer\u00e0"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Poblet"
                },
                {
                    "first": "Luis E.",
                    "initial": "L.E.",
                    "last": "Lombardi"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Bergeron"
                },
                {
                    "first": "Omar",
                    "initial": "O.",
                    "last": "Clavero"
                },
                {
                    "first": "Hai Rim",
                    "initial": "H.R.",
                    "last": "Shin"
                },
                {
                    "first": "Annabelle",
                    "initial": "A.",
                    "last": "Ferrera"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Felix"
                },
                {
                    "first": "Julieta",
                    "initial": "J.",
                    "last": "Germar"
                },
                {
                    "first": "Vaclav",
                    "initial": "V.",
                    "last": "Mandys"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Clavel"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Tzardi"
                },
                {
                    "first": "Luis E.",
                    "initial": "L.E.",
                    "last": "Pons"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Wain"
                },
                {
                    "first": "Eugenia",
                    "initial": "E.",
                    "last": "Cruz"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Molina"
                },
                {
                    "first": "Jose D.",
                    "initial": "J.D.",
                    "last": "Mota"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Jach"
                },
                {
                    "first": "Julio",
                    "initial": "J.",
                    "last": "Velasco"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Carrilho"
                },
                {
                    "first": "Ruben",
                    "initial": "R.",
                    "last": "L\u00f3pez-Revilla"
                },
                {
                    "first": "Marc T.",
                    "initial": "M.T.",
                    "last": "Goodman"
                },
                {
                    "first": "Wim G.",
                    "initial": "W.G.",
                    "last": "Quint"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Ignacio",
                    "initial": "I.",
                    "last": "Bravo"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Pawlita"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "De Sanjos\u00e9"
                }
            ],
            "doi": "10.1016/j.eururo.2015.12.007",
            "firstpage": "953",
            "issn": "03022838",
            "lastpage": "961",
            "pmid": "26762611",
            "pub_year": 2016,
            "title": "Role of Human Papillomavirus in Penile Carcinomas Worldwide",
            "volume": "69"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Laia",
                    "initial": "L.",
                    "last": "Alemany"
                },
                {
                    "first": "Ma\u00eblle",
                    "initial": "M.",
                    "last": "Saunier"
                },
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Alvarado-Cabrero"
                },
                {
                    "first": "Beatriz",
                    "initial": "B.",
                    "last": "Quir\u00f5s"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Salmeron"
                },
                {
                    "first": "Hai Rim",
                    "initial": "H.R.",
                    "last": "Shin"
                },
                {
                    "first": "Edyta C.",
                    "initial": "E.C.",
                    "last": "Pirog"
                },
                {
                    "first": "N\u00faria",
                    "initial": "N.",
                    "last": "Guimer\u00e0"
                },
                {
                    "first": "Gustavo",
                    "initial": "G.",
                    "last": "Hernandez-Suarez"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Felix"
                },
                {
                    "first": "Omar",
                    "initial": "O.",
                    "last": "Clavero"
                },
                {
                    "first": "Belen",
                    "initial": "B.",
                    "last": "Lloveras"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Kasamatsu"
                },
                {
                    "first": "Marc T.",
                    "initial": "M.T.",
                    "last": "Goodman"
                },
                {
                    "first": "Brenda Y.",
                    "initial": "B.Y.",
                    "last": "Hernandez"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Laco"
                },
                {
                    "first": "Leopoldo",
                    "initial": "L.",
                    "last": "Tinoco"
                },
                {
                    "first": "Daan T.",
                    "initial": "D.T.",
                    "last": "Geraets"
                },
                {
                    "first": "Charles F.",
                    "initial": "C.F.",
                    "last": "Lynch"
                },
                {
                    "first": "Vaclav",
                    "initial": "V.",
                    "last": "Mandys"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Poljak"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Jach"
                },
                {
                    "first": "Josep",
                    "initial": "J.",
                    "last": "Verge"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Clavel"
                },
                {
                    "first": "Cathy",
                    "initial": "C.",
                    "last": "Ndiaye"
                },
                {
                    "first": "Joellen",
                    "initial": "J.",
                    "last": "Klaustermeier"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Cubilla"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Ignacio G.",
                    "initial": "I.G.",
                    "last": "Bravo"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Pawlita"
                },
                {
                    "first": "William G.",
                    "initial": "W.G.",
                    "last": "Quint"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Francesc X.",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "De Sanjos\u00e9"
                }
            ],
            "doi": "10.1002/ijc.28963",
            "firstpage": "98",
            "issn": "00207136",
            "lastpage": "107",
            "pmid": "24817381",
            "pub_year": 2015,
            "title": "Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide",
            "volume": "136"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "de Sanjose"
                },
                {
                    "first": "Wim G.V.",
                    "initial": "W.G.V.",
                    "last": "Quint"
                },
                {
                    "first": "Laia",
                    "initial": "L.",
                    "last": "Alemany"
                },
                {
                    "first": "Daan T.",
                    "initial": "D.T.",
                    "last": "Geraets"
                },
                {
                    "first": "Jo Ellen",
                    "initial": "J.E.",
                    "last": "Klaustermeier"
                },
                {
                    "first": "Belen",
                    "initial": "B.",
                    "last": "Lloveras"
                },
                {
                    "first": "Sara",
                    "initial": "S.",
                    "last": "Tous"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Felix"
                },
                {
                    "first": "Luis Eduardo",
                    "initial": "L.E.",
                    "last": "Bravo"
                },
                {
                    "first": "Hai Rim",
                    "initial": "H.R.",
                    "last": "Shin"
                },
                {
                    "first": "Carlos S.",
                    "initial": "C.S.",
                    "last": "Vallejos"
                },
                {
                    "first": "Patricia Alonso",
                    "initial": "P.A.",
                    "last": "de Ruiz"
                },
                {
                    "first": "Marcus Aurelho",
                    "initial": "M.A.",
                    "last": "Lima"
                },
                {
                    "first": "Nuria",
                    "initial": "N.",
                    "last": "Guimera"
                },
                {
                    "first": "Omar",
                    "initial": "O.",
                    "last": "Clavero"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Alejo"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Llombart-Bosch"
                },
                {
                    "first": "Chou",
                    "initial": "C.",
                    "last": "Cheng-Yang"
                },
                {
                    "first": "Silvio Alejandro",
                    "initial": "S.A.",
                    "last": "Tatti"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Kasamatsu"
                },
                {
                    "first": "Ermina",
                    "initial": "E.",
                    "last": "Iljazovic"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Odida"
                },
                {
                    "first": "Rodrigo",
                    "initial": "R.",
                    "last": "Prado"
                },
                {
                    "first": "Muhieddine",
                    "initial": "M.",
                    "last": "Seoud"
                },
                {
                    "first": "Magdalena",
                    "initial": "M.",
                    "last": "Grce"
                },
                {
                    "first": "Alp",
                    "initial": "A.",
                    "last": "Usubutun"
                },
                {
                    "first": "Asha",
                    "initial": "A.",
                    "last": "Jain"
                },
                {
                    "first": "Gustavo Adolfo Hernandez",
                    "initial": "G.A.H.",
                    "last": "Suarez"
                },
                {
                    "first": "Luis Estuardo",
                    "initial": "L.E.",
                    "last": "Lombardi"
                },
                {
                    "first": "Aekunbiola",
                    "initial": "A.",
                    "last": "Banjo"
                },
                {
                    "first": "Clara",
                    "initial": "C.",
                    "last": "Men\u00e9ndez"
                },
                {
                    "first": "Efr\u00e9n Javier",
                    "initial": "E.J.",
                    "last": "Domingo"
                },
                {
                    "first": "Julio",
                    "initial": "J.",
                    "last": "Velasco"
                },
                {
                    "first": "Ashrafun",
                    "initial": "A.",
                    "last": "Nessa"
                },
                {
                    "first": "Saibua C.Bunnag",
                    "initial": "S.C.B.",
                    "last": "Chichareon"
                },
                {
                    "first": "You Lin",
                    "initial": "Y.L.",
                    "last": "Qiao"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Lerma"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Toshiyuki",
                    "initial": "T.",
                    "last": "Sasagawa"
                },
                {
                    "first": "Annabelle",
                    "initial": "A.",
                    "last": "Ferrera"
                },
                {
                    "first": "Doudja",
                    "initial": "D.",
                    "last": "Hammouda"
                },
                {
                    "first": "Luciano",
                    "initial": "L.",
                    "last": "Mariani"
                },
                {
                    "first": "Adela",
                    "initial": "A.",
                    "last": "Pelayo"
                },
                {
                    "first": "Ivo",
                    "initial": "I.",
                    "last": "Steiner"
                },
                {
                    "first": "Esther",
                    "initial": "E.",
                    "last": "Oliva"
                },
                {
                    "first": "Chris J.L.M.",
                    "initial": "C.J.L.M.",
                    "last": "Meijer"
                },
                {
                    "first": "Waleed Fahad",
                    "initial": "W.F.",
                    "last": "Al-Jassar"
                },
                {
                    "first": "Eugenia",
                    "initial": "E.",
                    "last": "Cruz"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Wright"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "Puras"
                },
                {
                    "first": "Cecilia Ladines",
                    "initial": "C.L.",
                    "last": "Llave"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Tzardi"
                },
                {
                    "first": "Theodoros",
                    "initial": "T.",
                    "last": "Agorastos"
                },
                {
                    "first": "Victoria",
                    "initial": "V.",
                    "last": "Garcia-Barriola"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Clavel"
                },
                {
                    "first": "Jaume",
                    "initial": "J.",
                    "last": "Ordi"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "And\u00fajar"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Gloria I.",
                    "initial": "G.I.",
                    "last": "S\u00e1nchez"
                },
                {
                    "first": "Andrzej Marcin",
                    "initial": "A.M.",
                    "last": "Nowakowski"
                },
                {
                    "first": "Jacob",
                    "initial": "J.",
                    "last": "Bornstein"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                }
            ],
            "doi": "10.1016/S1470-2045(10)70230-8",
            "firstpage": "1048",
            "issn": "14702045",
            "lastpage": "1056",
            "pmid": "20952254",
            "pub_year": 2010,
            "title": "Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study",
            "volume": "11"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Steben"
                },
                {
                    "first": "Heather L.",
                    "initial": "H.L.",
                    "last": "Sings"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "James"
                },
                {
                    "first": "Shuang",
                    "initial": "S.",
                    "last": "Lu"
                },
                {
                    "first": "Radha",
                    "initial": "R.",
                    "last": "Railkar"
                },
                {
                    "first": "Eliav",
                    "initial": "E.",
                    "last": "Barr"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Haupt"
                },
                {
                    "first": "Elmar A.",
                    "initial": "E.A.",
                    "last": "Joura"
                }
            ],
            "doi": "10.1086/597071",
            "firstpage": "805",
            "issn": "00221899",
            "lastpage": "814",
            "pmid": "19199546",
            "pub_year": 2009,
            "title": "Natural history of genital warts: Analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) Vaccine",
            "volume": "199"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Castellsagu\u00e9"
                },
                {
                    "first": "Laia",
                    "initial": "L.",
                    "last": "Alemany"
                },
                {
                    "first": "Miquel",
                    "initial": "M.",
                    "last": "Quer"
                },
                {
                    "first": "Gordana",
                    "initial": "G.",
                    "last": "Halec"
                },
                {
                    "first": "Beatriz",
                    "initial": "B.",
                    "last": "Quir\u00f3s"
                },
                {
                    "first": "Sara",
                    "initial": "S.",
                    "last": "Tous"
                },
                {
                    "first": "Omar",
                    "initial": "O.",
                    "last": "Clavero"
                },
                {
                    "first": "Ll\u00facia",
                    "initial": "L.",
                    "last": "Al\u00f2s"
                },
                {
                    "first": "Thorsten",
                    "initial": "T.",
                    "last": "Biegner"
                },
                {
                    "first": "Tomasz",
                    "initial": "T.",
                    "last": "Szafarowski"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Alejo"
                },
                {
                    "first": "Dana",
                    "initial": "D.",
                    "last": "Holzinger"
                },
                {
                    "first": "Enrique",
                    "initial": "E.",
                    "last": "Cadena"
                },
                {
                    "first": "Edith",
                    "initial": "E.",
                    "last": "Claros"
                },
                {
                    "first": "Gillian",
                    "initial": "G.",
                    "last": "Hall"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Laco"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Poljak"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Benevolo"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Kasamatsu"
                },
                {
                    "first": "Hisham",
                    "initial": "H.",
                    "last": "Mehanna"
                },
                {
                    "first": "Cathy",
                    "initial": "C.",
                    "last": "Ndiaye"
                },
                {
                    "first": "N\u00faria",
                    "initial": "N.",
                    "last": "Guimer\u00e0"
                },
                {
                    "first": "Belen",
                    "initial": "B.",
                    "last": "Lloveras"
                },
                {
                    "first": "Xavier",
                    "initial": "X.",
                    "last": "Le\u00f3n"
                },
                {
                    "first": "Juan C.",
                    "initial": "J.C.",
                    "last": "Ruiz-Cabezas"
                },
                {
                    "first": "Isabel",
                    "initial": "I.",
                    "last": "Alvarado-Cabrero"
                },
                {
                    "first": "Chang Suk",
                    "initial": "C.S.",
                    "last": "Kang"
                },
                {
                    "first": "Jin Kyoung",
                    "initial": "J.K.",
                    "last": "Oh"
                },
                {
                    "first": "Marcial",
                    "initial": "M.",
                    "last": "Garcia-Rojo"
                },
                {
                    "first": "Ermina",
                    "initial": "E.",
                    "last": "Iljazovic"
                },
                {
                    "first": "Oluseyi F.",
                    "initial": "O.F.",
                    "last": "Ajayi"
                },
                {
                    "first": "Flora",
                    "initial": "F.",
                    "last": "Duarte"
                },
                {
                    "first": "Ashrafun",
                    "initial": "A.",
                    "last": "Nessa"
                },
                {
                    "first": "Leopoldo",
                    "initial": "L.",
                    "last": "Tinoco"
                },
                {
                    "first": "Marco A.",
                    "initial": "M.A.",
                    "last": "Duran-Padilla"
                },
                {
                    "first": "Edyta C.",
                    "initial": "E.C.",
                    "last": "Pirog"
                },
                {
                    "first": "Halina",
                    "initial": "H.",
                    "last": "Viarheichyk"
                },
                {
                    "first": "Hesler",
                    "initial": "H.",
                    "last": "Morales"
                },
                {
                    "first": "Val\u00e9rie",
                    "initial": "V.",
                    "last": "Costes"
                },
                {
                    "first": "Ana",
                    "initial": "A.",
                    "last": "F\u00e9lix"
                },
                {
                    "first": "Maria Julieta V.",
                    "initial": "M.J.V.",
                    "last": "Germar"
                },
                {
                    "first": "Marisa",
                    "initial": "M.",
                    "last": "Mena"
                },
                {
                    "first": "Arzu",
                    "initial": "A.",
                    "last": "Ruacan"
                },
                {
                    "first": "Asha",
                    "initial": "A.",
                    "last": "Jain"
                },
                {
                    "first": "Ravi",
                    "initial": "R.",
                    "last": "Mehrotra"
                },
                {
                    "first": "Marc T.",
                    "initial": "M.T.",
                    "last": "Goodman"
                },
                {
                    "first": "Luis Estuardo",
                    "initial": "L.E.",
                    "last": "Lombardi"
                },
                {
                    "first": "Annabelle",
                    "initial": "A.",
                    "last": "Ferrera"
                },
                {
                    "first": "Sani",
                    "initial": "S.",
                    "last": "Malami"
                },
                {
                    "first": "Estela I.",
                    "initial": "E.I.",
                    "last": "Albanesi"
                },
                {
                    "first": "Pablo",
                    "initial": "P.",
                    "last": "Dabed"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Molina"
                },
                {
                    "first": "Rub\u00e9n",
                    "initial": "R.",
                    "last": "L\u00f3pez-Revilla"
                },
                {
                    "first": "V\u00e1clav",
                    "initial": "V.",
                    "last": "Mandys"
                },
                {
                    "first": "Manuel E.",
                    "initial": "M.E.",
                    "last": "Gonz\u00e1lez"
                },
                {
                    "first": "Julio",
                    "initial": "J.",
                    "last": "Velasco"
                },
                {
                    "first": "Ignacio G.",
                    "initial": "I.G.",
                    "last": "Bravo"
                },
                {
                    "first": "Wim",
                    "initial": "W.",
                    "last": "Quint"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Pawlita"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Silvia De",
                    "initial": "S.D.",
                    "last": "Sanjos\u00e9"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Xavier Bosch"
                }
            ],
            "doi": "10.1093/jnci/djv403",
            "issn": "00278874",
            "pmid": "26823521",
            "pub_year": 2016,
            "title": "HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients",
            "volume": "108"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "de Martel"
                },
                {
                    "first": "Martyn",
                    "initial": "M.",
                    "last": "Plummer"
                },
                {
                    "first": "Jerome",
                    "initial": "J.",
                    "last": "Vignat"
                },
                {
                    "first": "Silvia",
                    "initial": "S.",
                    "last": "Franceschi"
                }
            ],
            "doi": "10.1002/ijc.30716",
            "firstpage": "664",
            "issn": "00207136",
            "lastpage": "670",
            "pmid": "28369882",
            "pub_year": 2017,
            "title": "Worldwide burden of cancer attributable to HPV by site, country and HPV type",
            "volume": "141"
        },
        "b0035": {
            "authors": [],
            "firstpage": "241",
            "issn": "00498114",
            "lastpage": "268",
            "pmid": "28530369",
            "pub_year": 2017,
            "title": "Human papillomavirus vaccines: WHO position paper, May 2017",
            "volume": "92"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Jannah",
                    "initial": "J.",
                    "last": "Wigle"
                },
                {
                    "first": "Holly B.",
                    "initial": "H.B.",
                    "last": "Fontenot"
                },
                {
                    "first": "Gregory D.",
                    "initial": "G.D.",
                    "last": "Zimet"
                }
            ],
            "doi": "10.1016/j.pcl.2015.08.004",
            "firstpage": "81",
            "issn": "00313955",
            "lastpage": "95",
            "pmid": "26613690",
            "pub_year": 2016,
            "title": "Global Delivery of Human Papillomavirus Vaccines",
            "volume": "63"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Matti",
                    "initial": "M.",
                    "last": "Lehtinen"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Apter"
                }
            ],
            "doi": "10.1097/GCO.0000000000000208",
            "firstpage": "326",
            "issn": "1040872X",
            "lastpage": "332",
            "pmid": "26308204",
            "pub_year": 2015,
            "title": "Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination",
            "volume": "27"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Kathleen M.",
                    "initial": "K.M.",
                    "last": "Schmeler"
                },
                {
                    "first": "Erich M.",
                    "initial": "E.M.",
                    "last": "Sturgis"
                }
            ],
            "doi": "10.1016/S0140-6736(16)30314-2",
            "firstpage": "1798",
            "issn": "01406736",
            "lastpage": "1799",
            "pmid": "27203488",
            "pub_year": 2016,
            "title": "Expanding the benefits of HPV vaccination to boys and men",
            "volume": "387"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "Stanley"
                }
            ],
            "doi": "10.4161/hv.29138",
            "firstpage": "2106",
            "issn": "21645515",
            "lastpage": "2108",
            "pmid": "25608050",
            "pub_year": 2014,
            "title": "HPV vaccination in boys and men",
            "volume": "10"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Lisa G.",
                    "initial": "L.G.",
                    "last": "Johnson"
                },
                {
                    "first": "Margaret M.",
                    "initial": "M.M.",
                    "last": "Madeleine"
                },
                {
                    "first": "Laura M.",
                    "initial": "L.M.",
                    "last": "Newcomer"
                },
                {
                    "first": "Stephen M.",
                    "initial": "S.M.",
                    "last": "Schwartz"
                },
                {
                    "first": "Janet R.",
                    "initial": "J.R.",
                    "last": "Daling"
                }
            ],
            "doi": "10.1002/cncr.20364",
            "firstpage": "281",
            "issn": "0008543X",
            "lastpage": "288",
            "pmid": "15241824",
            "pub_year": 2004,
            "title": "Anal cancer incidence and survival: The Surveilance, epidemiology, and end results experience, 1973-2000",
            "volume": "101"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Kazufumi",
                    "initial": "K.",
                    "last": "Nakashima"
                },
                {
                    "first": "Kazuyoshi",
                    "initial": "K.",
                    "last": "Shigehara"
                },
                {
                    "first": "Shohei",
                    "initial": "S.",
                    "last": "Kawaguchi"
                },
                {
                    "first": "Akira",
                    "initial": "A.",
                    "last": "Wakatsuki"
                },
                {
                    "first": "Yoshitomo",
                    "initial": "Y.",
                    "last": "Kobori"
                },
                {
                    "first": "Kazuyoshi",
                    "initial": "K.",
                    "last": "Nakashima"
                },
                {
                    "first": "Yasunori",
                    "initial": "Y.",
                    "last": "Ishii"
                },
                {
                    "first": "Masayoshi",
                    "initial": "M.",
                    "last": "Shimamura"
                },
                {
                    "first": "Toshiyuki",
                    "initial": "T.",
                    "last": "Sasagawa"
                },
                {
                    "first": "Yasuhide",
                    "initial": "Y.",
                    "last": "Kitagawa"
                },
                {
                    "first": "Atsushi",
                    "initial": "A.",
                    "last": "Mizokami"
                },
                {
                    "first": "Mikio",
                    "initial": "M.",
                    "last": "Namiki"
                }
            ],
            "doi": "10.1186/1471-2334-14-43",
            "issn": "14712334",
            "pmid": "24468054",
            "pub_year": 2014,
            "title": "Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: A comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp",
            "volume": "14"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Mauricio",
                    "initial": "M.",
                    "last": "Hernandez-Avila"
                },
                {
                    "first": "Cosette M.",
                    "initial": "C.M.",
                    "last": "Wheeler"
                },
                {
                    "first": "Gonzalo",
                    "initial": "G.",
                    "last": "Perez"
                },
                {
                    "first": "Diane M.",
                    "initial": "D.M.",
                    "last": "Harper"
                },
                {
                    "first": "Sepp",
                    "initial": "S.",
                    "last": "Leodolter"
                },
                {
                    "first": "Grace W.K.",
                    "initial": "G.W.K.",
                    "last": "Tang"
                },
                {
                    "first": "Daron G.",
                    "initial": "D.G.",
                    "last": "Ferris"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Steben"
                },
                {
                    "first": "Janine",
                    "initial": "J.",
                    "last": "Bryan"
                },
                {
                    "first": "Frank J.",
                    "initial": "F.J.",
                    "last": "Taddeo"
                },
                {
                    "first": "Radha",
                    "initial": "R.",
                    "last": "Railkar"
                },
                {
                    "first": "Mark T.",
                    "initial": "M.T.",
                    "last": "Esser"
                },
                {
                    "first": "Heather L.",
                    "initial": "H.L.",
                    "last": "Sings"
                },
                {
                    "first": "Micki",
                    "initial": "M.",
                    "last": "Nelson"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Boslego"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Sattler"
                },
                {
                    "first": "Eliav",
                    "initial": "E.",
                    "last": "Barr"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Koutsky"
                }
            ],
            "doi": "10.1056/NEJMoa061760",
            "firstpage": "1928",
            "issn": "00284793",
            "lastpage": "1943",
            "pub_year": 2007,
            "title": "Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases",
            "volume": "356"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Luisa L.",
                    "initial": "L.L.",
                    "last": "Villa"
                },
                {
                    "first": "Gonzalo",
                    "initial": "G.",
                    "last": "Perez"
                },
                {
                    "first": "Susanne K.",
                    "initial": "S.K.",
                    "last": "Kjaer"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Paavonen"
                },
                {
                    "first": "Matti",
                    "initial": "M.",
                    "last": "Lehtinen"
                },
                {
                    "first": "Nubia",
                    "initial": "N.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Kristj\u00e1n",
                    "initial": "K.",
                    "last": "Sigurdsson"
                },
                {
                    "first": "Mauricio",
                    "initial": "M.",
                    "last": "Hernandez-Avila"
                },
                {
                    "first": "Finn Egil",
                    "initial": "F.E.",
                    "last": "Skjeldestad"
                },
                {
                    "first": "Steinar",
                    "initial": "S.",
                    "last": "Thoresen"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Garc\u00eda"
                },
                {
                    "first": "Slawomir",
                    "initial": "S.",
                    "last": "Majewski"
                },
                {
                    "first": "Joakim",
                    "initial": "J.",
                    "last": "Dillner"
                },
                {
                    "first": "Sven Eric",
                    "initial": "S.E.",
                    "last": "Olsson"
                },
                {
                    "first": "Hseon Tay",
                    "initial": "H.T.",
                    "last": "Eng"
                },
                {
                    "first": "F. Xavier",
                    "initial": "F.X.",
                    "last": "Bosch"
                },
                {
                    "first": "Kevin A.",
                    "initial": "K.A.",
                    "last": "Ault"
                },
                {
                    "first": "Darron R.",
                    "initial": "D.R.",
                    "last": "Brown"
                },
                {
                    "first": "Daron G.",
                    "initial": "D.G.",
                    "last": "Ferris"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Koutsky"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Kurman"
                },
                {
                    "first": "Evan R.",
                    "initial": "E.R.",
                    "last": "Myers"
                },
                {
                    "first": "Eliav",
                    "initial": "E.",
                    "last": "Barr"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Boslego"
                },
                {
                    "first": "Janine",
                    "initial": "J.",
                    "last": "Bryan"
                },
                {
                    "first": "Mark T.",
                    "initial": "M.T.",
                    "last": "Esser"
                },
                {
                    "first": "Christine K.",
                    "initial": "C.K.",
                    "last": "Gause"
                },
                {
                    "first": "Teresa M.",
                    "initial": "T.M.",
                    "last": "Hesley"
                },
                {
                    "first": "Lisa C.",
                    "initial": "L.C.",
                    "last": "Lupinacci"
                },
                {
                    "first": "Heather L.",
                    "initial": "H.L.",
                    "last": "Sings"
                },
                {
                    "first": "Frank J.",
                    "initial": "F.J.",
                    "last": "Taddeo"
                },
                {
                    "first": "Annemarie R.",
                    "initial": "A.R.",
                    "last": "Thornton"
                }
            ],
            "doi": "10.1056/NEJMoa061741",
            "firstpage": "1915",
            "issn": "00284793",
            "lastpage": "1927",
            "pub_year": 2007,
            "title": "Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions",
            "volume": "356"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Anna R.",
                    "initial": "A.R.",
                    "last": "Giuliano"
                },
                {
                    "first": "Joel M.",
                    "initial": "J.M.",
                    "last": "Palefsky"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Goldstone"
                },
                {
                    "first": "Edson D.",
                    "initial": "E.D.",
                    "last": "Moreira"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Penny"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Aranda"
                },
                {
                    "first": "Eftyhia",
                    "initial": "E.",
                    "last": "Vardas"
                },
                {
                    "first": "Harald",
                    "initial": "H.",
                    "last": "Moi"
                },
                {
                    "first": "Heiko",
                    "initial": "H.",
                    "last": "Jessen"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Hillman"
                },
                {
                    "first": "Yen Hwa",
                    "initial": "Y.H.",
                    "last": "Chang"
                },
                {
                    "first": "Daron",
                    "initial": "D.",
                    "last": "Ferris"
                },
                {
                    "first": "Danielle",
                    "initial": "D.",
                    "last": "Rouleau"
                },
                {
                    "first": "Janine",
                    "initial": "J.",
                    "last": "Bryan"
                },
                {
                    "first": "J. Brooke",
                    "initial": "J.B.",
                    "last": "Marshall"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Vuocolo"
                },
                {
                    "first": "Eliav",
                    "initial": "E.",
                    "last": "Barr"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Radley"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Haupt"
                },
                {
                    "first": "Dalya",
                    "initial": "D.",
                    "last": "Guris"
                }
            ],
            "doi": "10.1056/NEJMoa0909537",
            "firstpage": "401",
            "issn": "00284793",
            "lastpage": "411",
            "pub_year": 2011,
            "title": "Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males",
            "volume": "364"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Joel M.",
                    "initial": "J.M.",
                    "last": "Palefsky"
                },
                {
                    "first": "Anna R.",
                    "initial": "A.R.",
                    "last": "Giuliano"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Goldstone"
                },
                {
                    "first": "Edson D.",
                    "initial": "E.D.",
                    "last": "Moreira"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Aranda"
                },
                {
                    "first": "Heiko",
                    "initial": "H.",
                    "last": "Jessen"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Hillman"
                },
                {
                    "first": "Daron",
                    "initial": "D.",
                    "last": "Ferris"
                },
                {
                    "first": "Francois",
                    "initial": "F.",
                    "last": "Coutlee"
                },
                {
                    "first": "Mark H.",
                    "initial": "M.H.",
                    "last": "Stoler"
                },
                {
                    "first": "J. Brooke",
                    "initial": "J.B.",
                    "last": "Marshall"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Radley"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Vuocolo"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Haupt"
                },
                {
                    "first": "Dalya",
                    "initial": "D.",
                    "last": "Guris"
                },
                {
                    "first": "Elizabeth I.O.",
                    "initial": "E.I.O.",
                    "last": "Garner"
                }
            ],
            "doi": "10.1056/NEJMoa1010971",
            "firstpage": "1576",
            "issn": "00284793",
            "lastpage": "1585",
            "pmid": "22029979",
            "pub_year": 2011,
            "title": "HPV vaccine against anal HPV infection and anal intraepithelial neoplasia",
            "volume": "365"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Dennis",
                    "initial": "D.",
                    "last": "Dias"
                },
                {
                    "first": "Jeff",
                    "initial": "J.",
                    "last": "Van Doren"
                },
                {
                    "first": "Sonela",
                    "initial": "S.",
                    "last": "Schlottmann"
                },
                {
                    "first": "Sheri",
                    "initial": "S.",
                    "last": "Kelly"
                },
                {
                    "first": "Derek",
                    "initial": "D.",
                    "last": "Puchalski"
                },
                {
                    "first": "Wanda",
                    "initial": "W.",
                    "last": "Ruiz"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Boerckel"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Kessler"
                },
                {
                    "first": "Joseph M.",
                    "initial": "J.M.",
                    "last": "Antonello"
                },
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Green"
                },
                {
                    "first": "Martha",
                    "initial": "M.",
                    "last": "Brown"
                },
                {
                    "first": "Judith",
                    "initial": "J.",
                    "last": "Smith"
                },
                {
                    "first": "Narendra",
                    "initial": "N.",
                    "last": "Chirmule"
                },
                {
                    "first": "Eliav",
                    "initial": "E.",
                    "last": "Barr"
                },
                {
                    "first": "Kathrin U.",
                    "initial": "K.U.",
                    "last": "Jansen"
                },
                {
                    "first": "Mark T.",
                    "initial": "M.T.",
                    "last": "Esser"
                }
            ],
            "firstpage": "959",
            "issn": "1071412X",
            "lastpage": "969",
            "pmid": "16085914",
            "pub_year": 2005,
            "title": "Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18.",
            "volume": "12"
        },
        "b0095": null,
        "b0100": {
            "authors": [
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Hillman"
                },
                {
                    "first": "Anna R.",
                    "initial": "A.R.",
                    "last": "Giuliano"
                },
                {
                    "first": "Joel M.",
                    "initial": "J.M.",
                    "last": "Palefsky"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Goldstone"
                },
                {
                    "first": "Edson D.",
                    "initial": "E.D.",
                    "last": "Moreira"
                },
                {
                    "first": "Eftyhia",
                    "initial": "E.",
                    "last": "Vardas"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Aranda"
                },
                {
                    "first": "Heiko",
                    "initial": "H.",
                    "last": "Jessen"
                },
                {
                    "first": "Daron G.",
                    "initial": "D.G.",
                    "last": "Ferris"
                },
                {
                    "first": "Francois",
                    "initial": "F.",
                    "last": "Coutlee"
                },
                {
                    "first": "J. Brooke",
                    "initial": "J.B.",
                    "last": "Marshall"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Vuocolo"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Haupt"
                },
                {
                    "first": "Dalya",
                    "initial": "D.",
                    "last": "Guris"
                },
                {
                    "first": "Elizabeth I.O.",
                    "initial": "E.I.O.",
                    "last": "Garner"
                }
            ],
            "doi": "10.1128/CVI.05208-11",
            "firstpage": "261",
            "issn": "15566811",
            "lastpage": "267",
            "pmid": "22155768",
            "pub_year": 2012,
            "title": "Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old",
            "volume": "19"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Michelle",
                    "initial": "M.",
                    "last": "Vichnin"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Bonanni"
                },
                {
                    "first": "Nicola P.",
                    "initial": "N.P.",
                    "last": "Klein"
                },
                {
                    "first": "Suzanne M.",
                    "initial": "S.M.",
                    "last": "Garland"
                },
                {
                    "first": "Stan L.",
                    "initial": "S.L.",
                    "last": "Block"
                },
                {
                    "first": "Susanne K.",
                    "initial": "S.K.",
                    "last": "Kjaer"
                },
                {
                    "first": "Heather L.",
                    "initial": "H.L.",
                    "last": "Sings"
                },
                {
                    "first": "Gonzalo",
                    "initial": "G.",
                    "last": "Perez"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Haupt"
                },
                {
                    "first": "Alfred J.",
                    "initial": "A.J.",
                    "last": "Saah"
                },
                {
                    "first": "Fabio",
                    "initial": "F.",
                    "last": "Lievano"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Velicer"
                },
                {
                    "first": "Rosybel",
                    "initial": "R.",
                    "last": "Drury"
                },
                {
                    "first": "Barbara J.",
                    "initial": "B.J.",
                    "last": "Kuter"
                }
            ],
            "doi": "10.1097/INF.0000000000000793",
            "firstpage": "983",
            "issn": "08913668",
            "lastpage": "991",
            "pmid": "26107345",
            "pub_year": 2015,
            "title": "An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015",
            "volume": "34"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Edson D.",
                    "initial": "E.D.",
                    "last": "Moreira"
                },
                {
                    "first": "Joel M.",
                    "initial": "J.M.",
                    "last": "Palefsky"
                },
                {
                    "first": "Anna R.",
                    "initial": "A.R.",
                    "last": "Giuliano"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Goldstone"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Aranda"
                },
                {
                    "first": "Heiko",
                    "initial": "H.",
                    "last": "Jessen"
                },
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Hillman"
                },
                {
                    "first": "Daron",
                    "initial": "D.",
                    "last": "Ferris"
                },
                {
                    "first": "Francois",
                    "initial": "F.",
                    "last": "Coutlee"
                },
                {
                    "first": "Eftyhia",
                    "initial": "E.",
                    "last": "Vardas"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Brooke Marshall"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Vuocolo"
                },
                {
                    "first": "Richard M.",
                    "initial": "R.M.",
                    "last": "Haupt"
                },
                {
                    "first": "Dalya",
                    "initial": "D.",
                    "last": "Guris"
                },
                {
                    "first": "Elizabeth I.O.",
                    "initial": "E.I.O.",
                    "last": "Garner"
                }
            ],
            "doi": "10.4161/hv.7.7.15579",
            "firstpage": "768",
            "issn": "15548600",
            "lastpage": "775",
            "pmid": "21712645",
            "pub_year": 2011,
            "title": "Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults",
            "volume": "7"
        },
        "b0115": null,
        "b0120": {
            "authors": [
                {
                    "first": "Sadao",
                    "initial": "S.",
                    "last": "Suzuki"
                },
                {
                    "first": "Akihiro",
                    "initial": "A.",
                    "last": "Hosono"
                }
            ],
            "doi": "10.1016/j.pvr.2018.02.002",
            "firstpage": "96",
            "issn": "24058521",
            "lastpage": "103",
            "pmid": "29481964",
            "pub_year": 2018,
            "title": "No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study",
            "volume": "5"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Yusuke",
                    "initial": "Y.",
                    "last": "Tanaka"
                },
                {
                    "first": "Yutaka",
                    "initial": "Y.",
                    "last": "Ueda"
                },
                {
                    "first": "Tomomi",
                    "initial": "T.",
                    "last": "Egawa-Takata"
                },
                {
                    "first": "Asami",
                    "initial": "A.",
                    "last": "Yagi"
                },
                {
                    "first": "Kiyoshi",
                    "initial": "K.",
                    "last": "Yoshino"
                },
                {
                    "first": "Tadashi",
                    "initial": "T.",
                    "last": "Kimura"
                }
            ],
            "doi": "10.1016/S1470-2045(16)00147-9",
            "firstpage": "868",
            "issn": "14702045",
            "lastpage": "869",
            "pmid": "27396634",
            "pub_year": 2016,
            "title": "Outcomes for girls without HPV vaccination in Japan",
            "volume": "17"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Asami",
                    "initial": "A.",
                    "last": "Yagi"
                },
                {
                    "first": "Yutaka",
                    "initial": "Y.",
                    "last": "Ueda"
                },
                {
                    "first": "Tomomi",
                    "initial": "T.",
                    "last": "Egawa-Takata"
                },
                {
                    "first": "Yusuke",
                    "initial": "Y.",
                    "last": "Tanaka"
                },
                {
                    "first": "Ruriko",
                    "initial": "R.",
                    "last": "Nakae"
                },
                {
                    "first": "Akiko",
                    "initial": "A.",
                    "last": "Morimoto"
                },
                {
                    "first": "Yoshito",
                    "initial": "Y.",
                    "last": "Terai"
                },
                {
                    "first": "Masahide",
                    "initial": "M.",
                    "last": "Ohmichi"
                },
                {
                    "first": "Tomoyuki",
                    "initial": "T.",
                    "last": "Ichimura"
                },
                {
                    "first": "Toshiyuki",
                    "initial": "T.",
                    "last": "Sumi"
                },
                {
                    "first": "Hiromi",
                    "initial": "H.",
                    "last": "Murata"
                },
                {
                    "first": "Hidetaka",
                    "initial": "H.",
                    "last": "Okada"
                },
                {
                    "first": "Hidekatsu",
                    "initial": "H.",
                    "last": "Nakai"
                },
                {
                    "first": "Masaki",
                    "initial": "M.",
                    "last": "Mandai"
                },
                {
                    "first": "Shinya",
                    "initial": "S.",
                    "last": "Matsuzaki"
                },
                {
                    "first": "Eiji",
                    "initial": "E.",
                    "last": "Kobayashi"
                },
                {
                    "first": "Kiyoshi",
                    "initial": "K.",
                    "last": "Yoshino"
                },
                {
                    "first": "Tadashi",
                    "initial": "T.",
                    "last": "Kimura"
                },
                {
                    "first": "Junko",
                    "initial": "J.",
                    "last": "Saito"
                },
                {
                    "first": "Yumiko",
                    "initial": "Y.",
                    "last": "Hori"
                },
                {
                    "first": "Eiichi",
                    "initial": "E.",
                    "last": "Morii"
                },
                {
                    "first": "Tomio",
                    "initial": "T.",
                    "last": "Nakayama"
                },
                {
                    "first": "Yukio",
                    "initial": "Y.",
                    "last": "Suzuki"
                },
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Motoki"
                },
                {
                    "first": "Akiko",
                    "initial": "A.",
                    "last": "Sukegawa"
                },
                {
                    "first": "Mikiko",
                    "initial": "M.",
                    "last": "Asai-Sato"
                },
                {
                    "first": "Etsuko",
                    "initial": "E.",
                    "last": "Miyagi"
                },
                {
                    "first": "Manako",
                    "initial": "M.",
                    "last": "Yamaguchi"
                },
                {
                    "first": "Risa",
                    "initial": "R.",
                    "last": "Kudo"
                },
                {
                    "first": "Sosuke",
                    "initial": "S.",
                    "last": "Adachi"
                },
                {
                    "first": "Masayuki",
                    "initial": "M.",
                    "last": "Sekine"
                },
                {
                    "first": "Takayuki",
                    "initial": "T.",
                    "last": "Enomoto"
                },
                {
                    "first": "Yorihiko",
                    "initial": "Y.",
                    "last": "Horikoshi"
                },
                {
                    "first": "Tetsu",
                    "initial": "T.",
                    "last": "Takagi"
                },
                {
                    "first": "Kentaro",
                    "initial": "K.",
                    "last": "Shimura"
                }
            ],
            "doi": "10.1080/21645515.2017.1292190",
            "firstpage": "1700",
            "issn": "21645515",
            "lastpage": "1704",
            "pmid": "28272968",
            "pub_year": 2017,
            "title": "Realistic fear of cervical cancer risk in Japan depending on birth year",
            "volume": "13"
        }
    },
    "body_text": [
        {
            "endOffset": 20158,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study was conducted in accordance with principles of Good Clinical Practice and was approved by the appropriate institutional review boards and regulatory agencies; all participants (or, for minor participants, parent/legal guardian and participant) provided written informed consent.",
            "startOffset": 19870,
            "title": "Study design and participants"
        },
        {
            "endOffset": 15973,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 15972,
                    "startOffset": 15968
                },
                "b0060": {
                    "endOffset": 15897,
                    "startOffset": 15893
                }
            },
            "secId": "s0005",
            "sentence": "While anal cancer is relatively rare, the incidence is increasing [12], and screening programs for HPV-related cancers in men remain limited [10].",
            "startOffset": 15827,
            "title": "Introduction"
        },
        {
            "endOffset": 26852,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "In the PPE population, there were 12 cases of HPV6/11/16/18-related persistent infection (primary endpoint) in the placebo group compared with two in the qHPV vaccine group (vaccine efficacy: 83.3% [95% CI: 24.9, 98.2], p = 0.007) (Table 2).",
            "startOffset": 26611,
            "title": "Interim analysis"
        },
        {
            "endOffset": 24462,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Safety was assessed in all participants who received at least one vaccination and had follow-up data.",
            "startOffset": 24361,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 38659,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 38658,
                    "startOffset": 38651
                },
                "b0085": {
                    "endOffset": 38658,
                    "startOffset": 38651
                }
            },
            "secId": "s0065",
            "sentence": "However, vaccine efficacy against HPV-related disease in Japanese men is expected, as the efficacy against persistent infection and immunogenicity were similar to the international study in men that did not include Japan [16,17].",
            "startOffset": 38430,
            "title": "Discussion"
        },
        {
            "endOffset": 39051,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 39050,
                    "startOffset": 39047
                }
            },
            "secId": "s0065",
            "sentence": "Gender-neutral vaccination is expected to be most cost-effective in cases where HPV vaccination coverage in girls is below 50% [7].",
            "startOffset": 38920,
            "title": "Discussion"
        },
        {
            "endOffset": 39864,
            "parents": [],
            "secId": "s0080",
            "sentence": "All authors critically reviewed or revised the manuscript for important intellectual content, reviewed the final version of the manuscript and agreed with its content and submission.",
            "startOffset": 39682,
            "title": "Author contributions"
        },
        {
            "endOffset": 23767,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Vaccine efficacy was defined as (1 \u2212 RqHPV/Rplacebo) \u00d7 100 [%], where RqHPV and Rplacebo are incidence of persistent infection with qHPV vaccine and placebo, respectively.",
            "startOffset": 23596,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 32802,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "However, one participant in the placebo group died on Day 440 after completion of the three-dose regimen (suicide); this death was not considered vaccine related.",
            "startOffset": 32640,
            "title": "Safety"
        },
        {
            "endOffset": 25745,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The alpha boundary (\u03b1 = 0.0113) for the interim analysis was determined based on the Hwang-Shih-Decani alpha spending function (\u03b3 = \u22123.4) with the actual number of events observed up to the interim analysis.",
            "startOffset": 25538,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 39484,
            "parents": [],
            "secId": "s0080",
            "sentence": "All authors attest they meet the ICMJE criteria for authorship.",
            "startOffset": 39421,
            "title": "Author contributions"
        },
        {
            "endOffset": 39401,
            "parents": [],
            "secId": "s0075",
            "sentence": "SM, RY, SRH, AW, MS, and YT are employees of MSD K.K., Tokyo, Japan.",
            "startOffset": 39333,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 16105,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 16104,
                    "startOffset": 16100
                }
            },
            "secId": "s0005",
            "sentence": "In addition, genital warts is the most common viral sexually transmitted disease, with a lifetime risk of 10% in both genders [11].",
            "startOffset": 15974,
            "title": "Introduction"
        },
        {
            "endOffset": 16844,
            "parents": [],
            "secId": "s0005",
            "sentence": "We report data from the interim and final analyses of a randomized, placebo-controlled, multicenter study of qHPV vaccine in Japanese men aged 16\u201326 years.",
            "startOffset": 16689,
            "title": "Introduction"
        },
        {
            "endOffset": 30086,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "In supportive analyses conducted in the HNRT population, efficacy against HPV6/11/16/18-related persistent infection was 85.4% (95% CI: 58.2, 96.3; qHPV: 4 cases; placebo: 27 cases) (Supplementary material, Table 1).",
            "startOffset": 29870,
            "title": "Final analysis"
        },
        {
            "endOffset": 36165,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 36164,
                    "startOffset": 36160
                }
            },
            "secId": "s0065",
            "sentence": "Similar to the international study, GMTs were somewhat lower among MSM compared with HM [20].",
            "startOffset": 36072,
            "title": "Discussion"
        },
        {
            "endOffset": 36944,
            "parents": [],
            "secId": "s0065",
            "sentence": "The incidence of systemic AEs appeared to be lower in this study (qHPV: 14.4%; placebo: 15.4%) than in the international study (qHPV: 31.6%; placebo: 31.4%).",
            "startOffset": 36787,
            "title": "Discussion"
        },
        {
            "endOffset": 21809,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Persistent infection was defined as an HPV type detected in samples from two or more consecutive visits (\u00b11-month visit windows) at least 6 months apart.",
            "startOffset": 21656,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 37771,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 37770,
                    "startOffset": 37761
                },
                "b0080": {
                    "endOffset": 37770,
                    "startOffset": 37761
                },
                "b0105": {
                    "endOffset": 37770,
                    "startOffset": 37761
                }
            },
            "secId": "s0065",
            "sentence": "Global studies, including long-term safety in clinical trials and real-world findings in regions where the vaccine has been introduced over the past 10 years, support a favorable safety profile [7,16,21].",
            "startOffset": 37567,
            "title": "Discussion"
        },
        {
            "endOffset": 26423,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Baseline characteristics were well balanced across vaccination groups (Table 1).",
            "startOffset": 26343,
            "title": "Participants"
        },
        {
            "endOffset": 29870,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "Similarly, among subgroups of HM and MSM, efficacy was 100% (95% CI: 13.4, 100; qHPV: 0 cases; placebo: 6 cases) and 100% (95% CI: \u2212105.9, 100; qHPV: 0 cases; placebo: 3 cases), respectively (Table 3).",
            "startOffset": 29669,
            "title": "Final analysis"
        },
        {
            "endOffset": 31091,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Anti-HPV antibody GMTs were 67.5, 42.9, 203.0, and 32.6 mMU/mL for HPV 6, 11, 16, and 18, respectively, at Month 36 (Table 4).",
            "startOffset": 30965,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 35177,
            "parents": [],
            "secId": "s0065",
            "sentence": "However, intra-anal swab samples were collected from all participants, including HM and MSM participants.",
            "startOffset": 35072,
            "title": "Discussion"
        },
        {
            "endOffset": 26342,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "An additional 94 participants (n = 47, qHPV vaccine group; n = 47, placebo group) discontinued between Months 6 and 36.",
            "startOffset": 26223,
            "title": "Participants"
        },
        {
            "endOffset": 15679,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 15678,
                    "startOffset": 15672
                },
                "b0050": {
                    "endOffset": 15678,
                    "startOffset": 15672
                },
                "b0055": {
                    "endOffset": 15678,
                    "startOffset": 15672
                }
            },
            "secId": "s0005",
            "sentence": "Including males in HPV vaccination programs has potential to both prevent HPV-related disease in men and contribute to herd immunity by reducing the spread of HPV infection in males and females [9\u201311].",
            "startOffset": 15478,
            "title": "Introduction"
        },
        {
            "endOffset": 35524,
            "parents": [],
            "secId": "s0065",
            "sentence": "The incidence rate of intra-anal persistent infection in HM was observed to be lower than in MSM.",
            "startOffset": 35427,
            "title": "Discussion"
        },
        {
            "endOffset": 20289,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Vaccine or placebo were administered as 0.5-mL intramuscular injections on Day 1 and at Months 2 and 6.",
            "startOffset": 20186,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 23444,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The secondary efficacy analyses were conducted in the PPE population for all participants and also for subgroups of HM and MSM participants.",
            "startOffset": 23304,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 36786,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 36785,
                    "startOffset": 36781
                }
            },
            "secId": "s0065",
            "sentence": "Injection-site AEs were reported by similar proportions of Japanese men in the current study (qHPV: 59.7%; placebo: 55.3%) as previously by international male clinical trial participants (qHPV: 60.1%; placebo: 53.7%) [16].",
            "startOffset": 36564,
            "title": "Discussion"
        },
        {
            "endOffset": 37566,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 37565,
                    "startOffset": 37561
                }
            },
            "secId": "s0065",
            "sentence": "However, no causal association between HPV vaccines and suspected AEs is suggested, based on the results of a recent survey study of >29,000 female residents of Nagoya City [24].",
            "startOffset": 37388,
            "title": "Discussion"
        },
        {
            "endOffset": 38336,
            "parents": [],
            "secId": "s0065",
            "sentence": "This study does not have sufficient power to evaluate the disease endpoint (condyloma, PIN, AIN).",
            "startOffset": 38239,
            "title": "Discussion"
        },
        {
            "endOffset": 22099,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Participants were observed for at least 30 min after vaccination for any untoward effects, particularly allergic reactions.",
            "startOffset": 21976,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 38733,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 38732,
                    "startOffset": 38728
                }
            },
            "secId": "s0065",
            "sentence": "Currently in Japan, the female HPV vaccination rate is extremely low [26].",
            "startOffset": 38659,
            "title": "Discussion"
        },
        {
            "endOffset": 25043,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 25042,
                    "startOffset": 25038
                }
            },
            "secId": "s0025",
            "sentence": "The planned enrollment of 1100 participants was based on observed incidence rates of HPV6/11/16/18-related persistent infection in Asian men who received placebo in a global study of qHPV vaccine [16].",
            "startOffset": 24842,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 25846,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The trial had >56% power to detect significant vaccine efficacy if the true vaccine efficacy is 85%.",
            "startOffset": 25746,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29455,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "Thus, the efficacy against the combined incidence of HPV6/11/16/18-related persistent infection and external genital lesions was 86.5% (95% CI: 55.2, 97.4; p < 0.001) (Table 2).",
            "startOffset": 29278,
            "title": "Final analysis"
        },
        {
            "endOffset": 35947,
            "parents": [],
            "secId": "s0065",
            "sentence": "The qHPV vaccine elicited strong immune responses, with seroconversion to each HPV type observed in the vast majority (>97%) of participants at 1 month after the third vaccination, and efficacy was maintained at Month 36.",
            "startOffset": 35726,
            "title": "Discussion"
        },
        {
            "endOffset": 33639,
            "parents": [],
            "secId": "s0065",
            "sentence": "There were no cases of external genital lesions in either the vaccine or placebo group during the interim analysis.",
            "startOffset": 33524,
            "title": "Discussion"
        },
        {
            "endOffset": 17768,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Those with a history of genital warts, or clinically present external genital warts at Day 1, were excluded.",
            "startOffset": 17660,
            "title": "Study design and participants"
        },
        {
            "endOffset": 20466,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Each dose of the qHPV vaccine contained HPV6/11/16/18 L1 viral-like particles 20/40/40/20 \u00b5g, respectively, and 225 \u00b5g aluminum (as aluminum hydroxyphosphate sulfate adjuvant).",
            "startOffset": 20290,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 26222,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "A total of 61 participants (n = 31 qHPV vaccine; 30 placebo) discontinued from the trial before receiving all three vaccinations, most commonly due to loss to follow-up or withdrawal by participant.",
            "startOffset": 26024,
            "title": "Participants"
        },
        {
            "endOffset": 29046,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "Among subgroups of HM and MSM, efficacy was 87.4% (95% CI: 46.3, 98.6; qHPV: 2 cases; placebo: 16 cases over the entire study) and 83.6% (95% CI: \u221246.4, 99.7 qHPV: 1 case; placebo: 5 cases), respectively.",
            "startOffset": 28842,
            "title": "Final analysis"
        },
        {
            "endOffset": 25537,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The statistical criterion for success is based on the lower bound of the two-sided CI for vaccine efficacy being >0.",
            "startOffset": 25421,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 16981,
            "parents": [],
            "secId": "s0005",
            "sentence": "The primary objectives were to evaluate efficacy against HPV6/11/16/18-related persistent infection and tolerability in this population.",
            "startOffset": 16845,
            "title": "Introduction"
        },
        {
            "endOffset": 14673,
            "parents": [],
            "secId": "s0005",
            "sentence": "The quadrivalent (q) human papillomavirus (HPV) vaccine protects against infection and disease related to HPV6/11/16/18.",
            "startOffset": 14553,
            "title": "Introduction"
        },
        {
            "endOffset": 30526,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "At Month 7 (1 month after the last vaccination), seroconversion for HPV 6, 11, 16, and 18 occurred in 97.1\u2013100% of participants who received the qHPV vaccine (Table 4).",
            "startOffset": 30358,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 38919,
            "parents": [],
            "secId": "s0065",
            "sentence": "If this trend of low vaccination rates in Japanese girls continues, the inclusion of males in vaccination programs will become more important for the prevention of HPV-related diseases.",
            "startOffset": 38734,
            "title": "Discussion"
        },
        {
            "endOffset": 17293,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Heterosexual men (HM; n = 1004) must have had exclusively female sexual partners and 1\u20135 lifetime sexual partners at the time of enrollment.",
            "startOffset": 17153,
            "title": "Study design and participants"
        },
        {
            "endOffset": 17659,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Participants refrained from sexual activity for 2 days before scheduled visits that included sample collection.",
            "startOffset": 17548,
            "title": "Study design and participants"
        },
        {
            "endOffset": 35426,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 35294,
                    "startOffset": 35290
                }
            },
            "secId": "s0065",
            "sentence": "Although efficacy against intra-anal HPV infection in MSM was evaluated in a prior international clinical trial [17], this is the first clinical study to our knowledge to evaluate the efficacy of qHPV vaccine against intra-anal HPV infection in HM.",
            "startOffset": 35178,
            "title": "Discussion"
        },
        {
            "endOffset": 22389,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Information about vaccination-related SAEs and deaths was collected throughout the study.",
            "startOffset": 22300,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 30676,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Anti-HPV antibody GMTs were 384.1, 458.3, 2264.4, and 365.2 milli-Merck units (mMU)/mL for HPV 6, 11, 16, and 18, respectively, at Month 7 (Table 4).",
            "startOffset": 30527,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 32113,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The majority of injection-site AEs were mild or moderate in intensity and transient (i.e. most cases resolved within 1 week).",
            "startOffset": 31988,
            "title": "Safety"
        },
        {
            "endOffset": 18055,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All laboratory personnel, the pathology panel, the investigators, site personnel, and participants were blinded to the vaccination group.",
            "startOffset": 17918,
            "title": "Study design and participants"
        },
        {
            "endOffset": 19731,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "After the interim analysis, the study continued and the final study visit was completed at Month 36.",
            "startOffset": 19631,
            "title": "Study design and participants"
        },
        {
            "endOffset": 34153,
            "parents": [],
            "secId": "s0065",
            "sentence": "After the interim analysis, there were two cases of external genital lesions in the placebo group and none in the qHPV vaccine group.",
            "startOffset": 34020,
            "title": "Discussion"
        },
        {
            "endOffset": 24149,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Immunogenicity was assessed in the per-protocol immunogenicity population of participants who: received all three vaccinations within acceptable day ranges; provided blood samples for serology testing within an acceptable day range; did not have any major protocol violations; and were seronegative at Day 1 and PCR negative from Day 1 through Month 7 for the appropriate HPV types.",
            "startOffset": 23767,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 33276,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Three participants (all in the placebo group) discontinued vaccination due to AEs within 15 days following a vaccination: one due to bronchospasm (mild) on Day 4 following Vaccination 1 (resolved after 17 days [2.43 weeks]); one due to bronchitis (moderate) on Day 1 following Vaccination 1 (resolved at Week 1); and one due to injection-site erosion (moderate) on Day 4 following Vaccination 1 (resolved at Week 2).",
            "startOffset": 32860,
            "title": "Safety"
        },
        {
            "endOffset": 30964,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "At the end of the study (Month 36), 60.7\u201392.3% of participants who received the qHPV vaccine remained seropositive to HPV 6, 11, 16, and 18, respectively (Table 4).",
            "startOffset": 30800,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 22976,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Supportive analyses were conducted in the full analysis set (FAS) and na\u00efve to the relevant HPV type (HNRT) populations, with cases counted starting after Day 1.",
            "startOffset": 22815,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 20911,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Based on genitourinary and perianal inspections, all new (i.e. occurring after Day 1) lesions judged by the investigator to be possibly, probably, or definitely related to HPV or of unknown etiology were biopsied.",
            "startOffset": 20698,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 21084,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "External genital lesion biopsies were processed and read by a sponsor-designated central laboratory; the central laboratory diagnosis was used for case management purposes.",
            "startOffset": 20912,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 24361,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "HPV6/11/16/18-seroconversion percentages and GMT at Months 7 and 36 were evaluated by computing point estimates and constructing 95% confidence intervals (CIs) for all participants, and for HM and MSM subgroups.",
            "startOffset": 24150,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 19630,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Because significant results for the primary efficacy hypothesis were observed during the interim analysis, unblinding was performed and the primary analysis conducted.",
            "startOffset": 19463,
            "title": "Study design and participants"
        },
        {
            "endOffset": 21255,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Biopsy tissues were also reviewed by the HPV Vaccine Program Pathology Panel, and the panel consensus diagnosis was used to determine clinical disease efficacy endpoints.",
            "startOffset": 21085,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 15826,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 15825,
                    "startOffset": 15822
                }
            },
            "secId": "s0005",
            "sentence": "Approximately 60,000 male cancer cases are attributable to HPV annually, based on 2012 data, including anal, penile, and oropharyngeal cancer [6].",
            "startOffset": 15680,
            "title": "Introduction"
        },
        {
            "endOffset": 32573,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The most common vaccine-related systemic AEs were pyrexia (qHPV: 1.4%; placebo: 1.6%) and headache (qHPV: 0.4%; placebo: 1.3%).",
            "startOffset": 32446,
            "title": "Safety"
        },
        {
            "endOffset": 37387,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 37386,
                    "startOffset": 37379
                },
                "b0120": {
                    "endOffset": 37386,
                    "startOffset": 37379
                },
                "b0125": {
                    "endOffset": 37386,
                    "startOffset": 37379
                }
            },
            "secId": "s0065",
            "sentence": "While HPV vaccines with public aid became available to girls in Japan in 2010, the active recommendation for HPV vaccine in Japan was suspended in 2013 due to the occurrence of suspected AEs after vaccination, leading to a sharp decline in the newly vaccinated rate [23\u201325].",
            "startOffset": 37113,
            "title": "Discussion"
        },
        {
            "endOffset": 17152,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Protocol V501-122 (NCT01862874) was conducted at 24 sites in Japan, in healthy young men aged 16\u201326 years (N = 1124).",
            "startOffset": 17035,
            "title": "Study design and participants"
        },
        {
            "endOffset": 34562,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 34561,
                    "startOffset": 34557
                }
            },
            "secId": "s0065",
            "sentence": "In that study, efficacy against persistent HPV6/11/16/18-related persistent infection was 85.6% compared with placebo in the PPE population [16].",
            "startOffset": 34417,
            "title": "Discussion"
        },
        {
            "endOffset": 21364,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "HPV PCR analysis was performed on all external genital lesion specimens using Thinsection microtomy sections.",
            "startOffset": 21255,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 21655,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 21593,
                    "startOffset": 21589
                }
            },
            "secId": "s0020",
            "sentence": "Specimens for HPV (types 6/11/16/18/31/33/35/39/45/51/52/56/58/59) PCR testing were collected from the penis, scrotum, and perianal region using a nail file followed by a wetted DACRONTM swab system, as described previously [16]; an intra-anal sample was also collected for HPV PCR testing.",
            "startOffset": 21365,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 34019,
            "parents": [],
            "secId": "s0065",
            "sentence": "The efficacy observed at the time of the interim analysis continued without attenuation through Month 36 (85.9% efficacy against HPV6/11/16/18-related persistent infection at end of study).",
            "startOffset": 33830,
            "title": "Discussion"
        },
        {
            "endOffset": 35726,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 35564,
                    "startOffset": 35560
                }
            },
            "secId": "s0065",
            "sentence": "Similar to the international trial [17], this study demonstrated robust efficacy of the qHPV vaccine against intra-anal persistent infection in the overall population and in the MSM and HM populations.",
            "startOffset": 35525,
            "title": "Discussion"
        },
        {
            "endOffset": 27534,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "Thus, efficacy against the combined incidence of HPV6/11/16/18-related persistent infection and external genital lesions was 83.4% (95% CI: 25.6, 98.2), similar to efficacy against the endpoint of persistent infection only (Table 2).",
            "startOffset": 27301,
            "title": "Interim analysis"
        },
        {
            "endOffset": 18883,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Tolerability, based on adverse events (AEs), vaccination-related AEs, and new medical conditions, was also assessed as a primary objective, and immunogenicity (seroconversion percentages and geometric mean titers [GMT]) was evaluated as an exploratory endpoint.",
            "startOffset": 18622,
            "title": "Study design and participants"
        },
        {
            "endOffset": 20514,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The placebo doses contained the adjuvant alone.",
            "startOffset": 20467,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 29668,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "In the PPE population, there were nine cases of HPV6/11/16/18-related intra-anal persistent infection in the placebo group compared with none in the qHPV vaccine group (vaccine efficacy: 100% [95% CI: 49.3, 100]).",
            "startOffset": 29455,
            "title": "Final analysis"
        },
        {
            "endOffset": 15034,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15033,
                    "startOffset": 15028
                },
                "b0010": {
                    "endOffset": 15033,
                    "startOffset": 15028
                },
                "b0015": {
                    "endOffset": 15033,
                    "startOffset": 15028
                }
            },
            "secId": "s0005",
            "sentence": "In addition to preventing approximately 70% of cervical cancer cases attributable to HPV16/18 in women, the vaccine has potential to prevent more than 84% of anal cancers and 75% of anal intraepithelial neoplasia (AIN) Grade 2 and 3 lesions in both genders, and approximately 70% of HPV-positive penile cancers in men, based on global epidemiologic data [1\u20133].",
            "startOffset": 14674,
            "title": "Introduction"
        },
        {
            "endOffset": 19462,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Based on pre-specified criteria, the Data Monitoring Committee could recommend the primary analysis be conducted after accrual of 11 events; otherwise, it was to be conducted after accrual of 18 events.",
            "startOffset": 19260,
            "title": "Study design and participants"
        },
        {
            "endOffset": 20697,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Genitourinary examinations and collection of specimens for HPV polymerase chain reaction (PCR) testing were performed on Day 1 and at Month 7, Month 12, and every 6 months thereafter.",
            "startOffset": 20514,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 32860,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "No other SAEs were reported over the entire study period.",
            "startOffset": 32803,
            "title": "Safety"
        },
        {
            "endOffset": 36071,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 36070,
                    "startOffset": 36066
                }
            },
            "secId": "s0065",
            "sentence": "These results were consistent with the robust immune responses observed in the prior international study in young men [20].",
            "startOffset": 35948,
            "title": "Discussion"
        },
        {
            "endOffset": 32325,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Systemic AEs were reported in 14.4% of qHPV vaccine and 15.4% of placebo recipients; of those, 3.4% and 5.0% of participants, respectively, experienced systemic AEs that were considered vaccine related (Table 5).",
            "startOffset": 32113,
            "title": "Safety"
        },
        {
            "endOffset": 18404,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The primary efficacy endpoint was the combined incidence of HPV6/11/16/18-related persistent (\u22656 months) infection, and the secondary efficacy endpoint was the combined incidence of HPV6/11/16/18-related persistent infection, condyloma acuminata, and penile/perianal/perineal intraepithelial neoplasia (PIN), or penile, perianal, or perineal cancer.",
            "startOffset": 18055,
            "title": "Study design and participants"
        },
        {
            "endOffset": 16688,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 16626,
                    "startOffset": 16619
                },
                "b0085": {
                    "endOffset": 16626,
                    "startOffset": 16619
                }
            },
            "secId": "s0005",
            "sentence": "In men, the qHPV vaccine prevented HPV6/11/16/18-related external genital lesions, AIN, and persistent infection in an international clinical trial [16,17]; however, this study did not include participants from Japan.",
            "startOffset": 16471,
            "title": "Introduction"
        },
        {
            "endOffset": 21976,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 21975,
                    "startOffset": 21971
                }
            },
            "secId": "s0020",
            "sentence": "For immunogenicity assessments, anti-HPV6/11/16/18 antibodies were detected in serum collected on Day 1 and at Months 7 and 36 by competitive Luminex immunoassay [18].",
            "startOffset": 21809,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 28637,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "At the end of the study, there were an additional nine cases and one case of HPV6/11/16/18-related persistent infection in the placebo and qHPV vaccine groups, respectively, in the PPE population.",
            "startOffset": 28441,
            "title": "Final analysis"
        },
        {
            "endOffset": 26995,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "Of the two cases of HPV6/11/16/18-related persistent infection observed in the qHPV vaccine group, one was HPV6 related and one HPV16 related.",
            "startOffset": 26853,
            "title": "Interim analysis"
        },
        {
            "endOffset": 18621,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Other efficacy endpoints included the combined incidence of HPV6/11/16/18-related intra-anal persistent infection.",
            "startOffset": 18507,
            "title": "Study design and participants"
        },
        {
            "endOffset": 33829,
            "parents": [],
            "secId": "s0065",
            "sentence": "Therefore, efficacy against the combined endpoint of HPV6/11/16/18-related persistent infection and disease (83.4%) was nearly identical to that observed against persistent infection alone.",
            "startOffset": 33640,
            "title": "Discussion"
        },
        {
            "endOffset": 31856,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Vaccination-related injection-site AEs were reported in 59.6% (n = 330) and 55.1% (n = 308) of qHPV vaccine and placebo recipients, respectively; the most common were injection-site pain, erythema, and swelling (Table 5).",
            "startOffset": 31635,
            "title": "Safety"
        },
        {
            "endOffset": 28841,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "The efficacy against the incidence of HPV6/11/16/18-related persistent infection was 85.9% (95% CI: 52.7, 97.3; p < 0.001), similar to that observed in the interim analysis without attenuation (Table 2).",
            "startOffset": 28638,
            "title": "Final analysis"
        },
        {
            "endOffset": 32445,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The frequencies of individual systemic AEs and vaccine-related systemic AEs were similar with qHPV vaccine and placebo.",
            "startOffset": 32326,
            "title": "Safety"
        },
        {
            "endOffset": 33523,
            "parents": [],
            "secId": "s0065",
            "sentence": "In the interim analysis, the qHPV vaccine demonstrated robust efficacy (83.3%) against HPV6/11/16/18-related persistent (\u22656 months) infection in young Japanese men.",
            "startOffset": 33359,
            "title": "Discussion"
        },
        {
            "endOffset": 17547,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Men who have sex with men (MSM; n = 120) must have engaged in either insertive or receptive anal intercourse or oral sex with a male sexual partner within the past year and must have had up to 5 lifetime male and/or female sexual partners at enrollment.",
            "startOffset": 17294,
            "title": "Study design and participants"
        },
        {
            "endOffset": 38124,
            "parents": [],
            "secId": "s0065",
            "sentence": "Findings from this study further support implementation of widespread vaccination in Japan.",
            "startOffset": 38033,
            "title": "Discussion"
        },
        {
            "endOffset": 38429,
            "parents": [],
            "secId": "s0065",
            "sentence": "There were only two cases of HPV6/11/16/18-related anogenital disease at the final analysis.",
            "startOffset": 38337,
            "title": "Discussion"
        },
        {
            "endOffset": 30341,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "In the FAS, which included participants who were infected with vaccine HPV types at baseline, efficacy against HPV6/11/16/18-related persistent infection was 61.8% (95% CI: 27.4, 81.0; qHPV: 14 cases; placebo: 36 cases) (Supplementary material, Table 2).",
            "startOffset": 30087,
            "title": "Final analysis"
        },
        {
            "endOffset": 37113,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 37038,
                    "startOffset": 37031
                },
                "b0095": {
                    "endOffset": 37112,
                    "startOffset": 37108
                },
                "b0110": {
                    "endOffset": 37038,
                    "startOffset": 37031
                }
            },
            "secId": "s0065",
            "sentence": "No serious vaccine-related AEs were reported here or in the prior international study [16,22], including in a long-term extension with up to 10 years of follow-up [19].",
            "startOffset": 36945,
            "title": "Discussion"
        },
        {
            "endOffset": 15477,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 15476,
                    "startOffset": 15471
                },
                "b0040": {
                    "endOffset": 15476,
                    "startOffset": 15471
                }
            },
            "secId": "s0005",
            "sentence": "The HPV vaccine is included in the immunization programs of more than 70 countries, of which at least 11 include boys [7,8].",
            "startOffset": 15353,
            "title": "Introduction"
        },
        {
            "endOffset": 22299,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Information about oral temperature (Days 1\u20135), injection-site AEs (Days 1\u20135), systemic AEs, and serious AEs (SAEs) was collected using vaccination report cards for 15 days following each vaccination.",
            "startOffset": 22100,
            "title": "Vaccination and follow-up"
        },
        {
            "endOffset": 24842,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For vaccination report card-recorded injection-site AEs and temperature elevations (\u226537.5 \u00b0C), across all vaccination visits, treatment differences (incidence qHPV vaccine\u2013placebo) and 95% CIs were calculated using the Miettinen and Nurminen method.",
            "startOffset": 24593,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29143,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "There were no cases of HPV6/11/16/18-related external genital lesions in the qHPV vaccine group.",
            "startOffset": 29047,
            "title": "Final analysis"
        },
        {
            "endOffset": 39277,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Discussion"
                }
            ],
            "secId": "s0070",
            "sentence": "In this study, the qHPV vaccine demonstrated efficacy against vaccine-type\u2013related persistent infection, elicited robust immune responses, and was not associated with any new safety signals in young Japanese men.",
            "startOffset": 39065,
            "title": "Conclusions"
        },
        {
            "endOffset": 27952,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "Similarly, among subgroups of HM and MSM, efficacy was 100% (95% CI: \u2212442.6, 100; qHPV: 0 cases; placebo: 2 cases) and 100% (95% CI: \u2212344.9, 100; qHPV: 0 cases; placebo: 2 cases), respectively (Table 3).",
            "startOffset": 27749,
            "title": "Interim analysis"
        },
        {
            "endOffset": 15353,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 15260,
                    "startOffset": 15257
                },
                "b0030": {
                    "endOffset": 15352,
                    "startOffset": 15349
                }
            },
            "secId": "s0005",
            "sentence": "A large proportion of oropharyngeal cancers (estimated 18.5\u201322.4%) are also believed to be driven by HPV [5], with the majority of HPV-attributable head and neck cancers caused by HPV16/18 (84.9%) [6].",
            "startOffset": 15152,
            "title": "Introduction"
        },
        {
            "endOffset": 38238,
            "parents": [],
            "secId": "s0065",
            "sentence": "The present findings should be considered in the context of limitations related to sample size and study duration.",
            "startOffset": 38124,
            "title": "Discussion"
        },
        {
            "endOffset": 27178,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "Among subgroups of HM and MSM, efficacy was 77.3% (95% CI: \u22129.8, 97.6; qHPV: 2 cases; placebo: 9 cases) and 100% (95% CI: \u2212107.9, 100; qHPV: 0 cases; placebo: 3 cases), respectively.",
            "startOffset": 26996,
            "title": "Interim analysis"
        },
        {
            "endOffset": 24592,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "AEs were summarized as frequencies and percentages by vaccination group, by vaccination visit, and across all vaccination visits.",
            "startOffset": 24463,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 27300,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "No cases of HPV6/11/16/18-related external genital lesions were observed in the qHPV vaccine or placebo groups (Table 2).",
            "startOffset": 27179,
            "title": "Interim analysis"
        },
        {
            "endOffset": 15151,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 15150,
                    "startOffset": 15147
                }
            },
            "secId": "s0005",
            "sentence": "The qHPV vaccine also has potential to prevent approximately 90% of genital warts cases attributable to HPV6/11 [4].",
            "startOffset": 15035,
            "title": "Introduction"
        },
        {
            "endOffset": 30799,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "GMTs were generally higher in the HM subgroup compared with the MSM subgroup at Month 7 (Supplementary material, Table 3).",
            "startOffset": 30677,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 18506,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The incidence of HPV6/11/16/18-related condyloma acuminata was a pre-specified exploratory objective.",
            "startOffset": 18405,
            "title": "Study design and participants"
        },
        {
            "endOffset": 25420,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Based on an estimated incidence rate of HPV6/11/16/18-related persistent infection of 2.3 per 100 person-years, and assuming a vaccine efficacy of 85%, approximately 59% of enrolled participants would have evaluable data, and one interim analysis when 11 persistent infection cases were observed, the study has at least 90% power to achieve success for the primary hypothesis.",
            "startOffset": 25044,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 18985,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The event-driven primary analysis was planned after observation of at least 18 primary efficacy cases.",
            "startOffset": 18883,
            "title": "Study design and participants"
        },
        {
            "endOffset": 31248,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Similar to the Month 7 analysis, GMTs were generally higher in the HM subgroup compared with the MSM subgroup at Month 36 (Supplementary material, Table 3).",
            "startOffset": 31092,
            "title": "Immunogenicity"
        },
        {
            "endOffset": 36563,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 36511,
                    "startOffset": 36505
                },
                "b0105": {
                    "endOffset": 36511,
                    "startOffset": 36505
                }
            },
            "secId": "s0065",
            "sentence": "Consistent with the established safety profile of the qHPV vaccine [7,21], injection-site reactions were the most common AEs.",
            "startOffset": 36438,
            "title": "Discussion"
        },
        {
            "endOffset": 26023,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Beginning on June 28, 2013, 1124 participants were randomized, 1123 received at least one vaccination, and 1062 completed all three vaccinations (Fig. 1).",
            "startOffset": 25869,
            "title": "Participants"
        },
        {
            "endOffset": 34744,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 34743,
                    "startOffset": 34736
                },
                "b0085": {
                    "endOffset": 34743,
                    "startOffset": 34736
                }
            },
            "secId": "s0065",
            "sentence": "High efficacy against HPV6/11/16/18-related external genital lesions (90.4%) and AIN of any grade (77.5%) or high grade (74.9%) was also observed in the international study [16,17].",
            "startOffset": 34563,
            "title": "Discussion"
        },
        {
            "endOffset": 36437,
            "parents": [],
            "secId": "s0065",
            "sentence": "The vaccine was generally well tolerated, with no SAEs reported within 15 days of any vaccination.",
            "startOffset": 36339,
            "title": "Discussion"
        },
        {
            "endOffset": 17917,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Participants were randomized in a 1:1 ratio to receive qHPV vaccine or placebo via a central integrated web response system, stratified by HM or MSM.",
            "startOffset": 17768,
            "title": "Study design and participants"
        },
        {
            "endOffset": 28168,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "In supportive analyses conducted in the HNRT population, efficacy against HPV6/11/16/18-related persistent infection was 88.8% (95% CI: 53.4, 98.7; qHPV: 2 cases; placebo: 18 cases) (Supplementary material, Table 1).",
            "startOffset": 27952,
            "title": "Interim analysis"
        },
        {
            "endOffset": 16317,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 16316,
                    "startOffset": 16312
                }
            },
            "secId": "s0005",
            "sentence": "HPV infection is common in Japanese men: a study of Japanese men attending a sexually transmitted disease clinic reported HPV prevalence of approximately 19% and 22% in oral and urine samples, respectively [13].",
            "startOffset": 16106,
            "title": "Introduction"
        },
        {
            "endOffset": 33348,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "These events were considered by the investigator to be vaccine related.",
            "startOffset": 33277,
            "title": "Safety"
        },
        {
            "endOffset": 34958,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 34957,
                    "startOffset": 34953
                }
            },
            "secId": "s0065",
            "sentence": "Moreover, in an extension study with up to 10 years of follow-up, durable protection from vaccine HPV-type\u2013related genital warts, external genital lesions, and AIN plus sustained immunogenicity were reported [19].",
            "startOffset": 34745,
            "title": "Discussion"
        },
        {
            "endOffset": 35071,
            "parents": [],
            "secId": "s0065",
            "sentence": "In this study, detailed anal inspection was not conducted and, therefore, no cases of anal lesions were observed.",
            "startOffset": 34958,
            "title": "Discussion"
        },
        {
            "endOffset": 23595,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The primary efficacy hypothesis was tested using a one-sided exact test, based on a binomial distribution that conditions on the total number of cases.",
            "startOffset": 23444,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 31382,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The incidence of AEs and vaccination-related AEs was generally similar between the qHPV vaccine and placebo groups (Table 5).",
            "startOffset": 31257,
            "title": "Safety"
        },
        {
            "endOffset": 32639,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "No SAEs were reported within 15 days of any vaccination (Table 5).",
            "startOffset": 32573,
            "title": "Safety"
        },
        {
            "endOffset": 31635,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The incidence of overall and vaccination-related AEs within 15 days following any vaccination was 63.9% (n = 354) and 60.8% (n = 337) in the qHPV group, respectively, and 59.9% (n = 335) and 56.5% (n = 316) in the placebo group, respectively (Table 5).",
            "startOffset": 31383,
            "title": "Safety"
        },
        {
            "endOffset": 36339,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 36338,
                    "startOffset": 36334
                }
            },
            "secId": "s0065",
            "sentence": "However, the differences in GMTs do not appear to be clinically relevant, as high efficacy of qHPV vaccine has been demonstrated across a wide range of antibody levels [20].",
            "startOffset": 36166,
            "title": "Discussion"
        },
        {
            "endOffset": 39681,
            "parents": [],
            "secId": "s0080",
            "sentence": "SM, RY, SRH, AW, MS, and YT contributed to conception, design, or planning the study; YY and SRH contributed to data analysis; RY acquired data; HM, SM, RY, AW, MS, and YT interpreted the results.",
            "startOffset": 39485,
            "title": "Author contributions"
        },
        {
            "endOffset": 19870,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "We report the results from this interim analysis (database lock: April 24, 2017) and the final analysis (database lock: February 5, 2018).",
            "startOffset": 19732,
            "title": "Study design and participants"
        },
        {
            "endOffset": 34416,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 34415,
                    "startOffset": 34411
                }
            },
            "secId": "s0065",
            "sentence": "The observed qHPV vaccine efficacy against the collective incidence of HPV6/11/16/18-related persistent infection among Japanese men is consistent with results from a prior international clinical trial in young men that did not include Japanese participants [16].",
            "startOffset": 34153,
            "title": "Discussion"
        },
        {
            "endOffset": 38032,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 38031,
                    "startOffset": 38025
                },
                "b0115": {
                    "endOffset": 38031,
                    "startOffset": 38025
                }
            },
            "secId": "s0065",
            "sentence": "The World Health Organization Global Advisory Committee on Vaccine Safety has concluded that the available evidence does not indicate any safety concerns to date that would alter the World Health Organization recommendations for use of the qHPV vaccine [7,23].",
            "startOffset": 37772,
            "title": "Discussion"
        },
        {
            "endOffset": 19259,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A pre-specified interim analysis was conducted when at least 11 cases were observed and reviewed by the external Data Monitoring Committee, which was formed to conduct interim analysis and make recommendations to the sponsor based on reviewing the interim analysis results.",
            "startOffset": 18986,
            "title": "Study design and participants"
        },
        {
            "endOffset": 28422,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "In the FAS, which included participants who were infected with vaccine HPV types at baseline, efficacy against HPV6/11/16/18-related persistent infection was 55.4% (95% CI: 9.0, 79.4; qHPV: 12 cases; placebo: 27 cases) (Supplementary material, Table 2).",
            "startOffset": 28169,
            "title": "Interim analysis"
        },
        {
            "endOffset": 31987,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Injection-site pain and swelling were more common with qHPV vaccine than placebo (each p < 0.05; Supplementary material, Table 4).",
            "startOffset": 31857,
            "title": "Safety"
        },
        {
            "endOffset": 16470,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 16469,
                    "startOffset": 16462
                },
                "b0075": {
                    "endOffset": 16469,
                    "startOffset": 16462
                }
            },
            "secId": "s0005",
            "sentence": "In pivotal clinical trials in young women, the qHPV vaccine demonstrated efficacy against HPV6/11/16/18-related persistent infection and disease [14,15].",
            "startOffset": 16317,
            "title": "Introduction"
        },
        {
            "endOffset": 27748,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0045",
            "sentence": "In the PPE population, there were four cases of HPV6/11/16/18-related intra-anal persistent infection in the placebo group compared with none in the qHPV vaccine group (vaccine efficacy: 100% [95% CI: \u221251.2, 100]).",
            "startOffset": 27534,
            "title": "Interim analysis"
        },
        {
            "endOffset": 39332,
            "parents": [],
            "secId": "s0075",
            "sentence": "HM and YY have nothing to disclose.",
            "startOffset": 39297,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 26516,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The mean age in both groups was 22.6 years, and 89.3% of participants were HM in each group.",
            "startOffset": 26424,
            "title": "Participants"
        },
        {
            "endOffset": 23303,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The HNRT population included those participants who received at least one vaccination and had any follow-up visit who were seronegative and PCR negative at Day 1 to the relevant HPV type.",
            "startOffset": 23116,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 22814,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The primary efficacy analysis was conducted in the per-protocol efficacy (PPE) population, which included participants who: received all three vaccinations within 1 year; did not have any protocol deviations that could potentially interfere with the vaccine efficacy; had at least one follow-up after Month 7; and were seronegative at Day 1 and PCR negative from Day 1 through Month 7 to HPV6/11/16/18.",
            "startOffset": 22412,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 29277,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0040",
                    "title": "Efficacy against HPV6/11/16/18-related persistent infection and disease"
                }
            ],
            "secId": "s0050",
            "sentence": "Two cases of HPV6/11/16/18-related external genital lesions were observed in the placebo group: one case each of condyloma and PIN 1.",
            "startOffset": 29144,
            "title": "Final analysis"
        },
        {
            "endOffset": 23115,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The FAS included all participants who received at least one vaccination and had any follow-up visit, regardless of HPV status at baseline.",
            "startOffset": 22977,
            "title": "Statistical analysis"
        }
    ],
    "docId": "S0264410X19301549",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Hiroshige",
                "initial": "H.",
                "last": "Mikamo"
            },
            {
                "email": null,
                "first": "Yuka",
                "initial": "Y.",
                "last": "Yamagishi"
            },
            {
                "email": "shinya.murata@merck.com",
                "first": "Shinya",
                "initial": "S.",
                "last": "Murata"
            },
            {
                "email": null,
                "first": "Ruriko",
                "initial": "R.",
                "last": "Yokokawa"
            },
            {
                "email": null,
                "first": "Shi Rong",
                "initial": "S.R.",
                "last": "Han"
            },
            {
                "email": null,
                "first": "Akira",
                "initial": "A.",
                "last": "Wakana"
            },
            {
                "email": null,
                "first": "Miyuki",
                "initial": "M.",
                "last": "Sawata"
            },
            {
                "email": null,
                "first": "Yoshiyuki",
                "initial": "Y.",
                "last": "Tanaka"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.01.069",
        "firstpage": "1651",
        "issn": "0264410X",
        "keywords": [
            "Adult male",
            "Human papillomavirus",
            "Japan",
            "Prophylactic efficacy",
            "Quadrivalent HPV vaccine",
            "Safety"
        ],
        "lastpage": "1658",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study"
    }
}